CAS 158985-00-3

3-[[4-(4-Chlorophenyl)-1-piperazinyl]methyl]-1H-pyrrolo[2,3-b]pyridine

Description:

3-[[4-(4-Chlorophenyl)-1-piperazinyl]methyl]-1H-pyrrolo[2,3-b]pyridine, with CAS number 158985-00-3, is a chemical compound that belongs to the class of pyrrolopyridines. This substance features a complex structure characterized by a pyrrolopyridine core, which is fused with a piperazine moiety. The presence of a 4-chlorophenyl group enhances its pharmacological properties, potentially influencing its interaction with biological targets. Typically, compounds of this nature are investigated for their potential therapeutic applications, particularly in the fields of psychiatry and neurology, due to their ability to modulate neurotransmitter systems. The compound may exhibit properties such as high lipophilicity, which can affect its bioavailability and distribution in biological systems. Additionally, its molecular structure suggests potential for various chemical reactions, making it a candidate for further synthetic modifications. Safety and handling considerations are essential, as with any chemical substance, particularly in research and pharmaceutical contexts.

Formula: C₁₈H₁₉ClN₄

InChI: InChI=1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)

InChI key: InChIKey=OGJGQVFWEPNYSB-UHFFFAOYSA-N

SMILES: C(C=1C=2C(NC1)=NC=CC2)N3CCN(CC3)C4=CC=C(Cl)C=C4

Synonyms:

• 1H-Pyrrolo[2,3-b]pyridine, 3-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-
• 3-(4-[4-Chlorophenyl]Piperazin-1-Yl)-Methyl-1H-Pyrrolo[2,3-B]Pyridine Trihydrochloride
• 3-[[4-(4-Chlorophenyl)-1-piperazinyl]methyl]-1H-pyrrolo[2,3-b]pyridine
• 3HCl
• L 745870

L-745870

CAS: 158985-00-3

Formula: C₁₈H₁₉ClN₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 326.8233

Ref: IN-DA001R30

L-745870

CAS: 158985-00-3

L-745870

Molecular weight: 326.82g/mol

Ref: 54-BUP18592

L-745870

CAS: 158985-00-3

L-745870 is a D4 receptor antagonist that also inhibits D2 receptors, 5-HT2 receptors, and α-adrenergic receptors.

Formula: C₁₈H₁₉ClN₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 326.82

Ref: TM-T11799L

L-745870

CAS: 158985-00-3

L-745870 is a drug that has been shown to have an inhibitory effect on monoamine neurotransmitter levels. It is currently being investigated as a potential treatment for symptoms of Parkinson's disease. L-745870 binds to the oxytocin receptor and inhibits serine protease activity, thereby reducing the production of dopamine and other monoamines. In humans, L-745870 has been shown to increase locomotor activity in doses that do not cause any adverse side effects. The effective dose for L-745870 is 10 mg/kg, and it reaches its maximal response at 60 minutes after administration. This drug also has an excellent profile with regard to pharmacokinetics and safety.

Formula: C₁₈H₁₉ClN₄

Purity: Min. 95%

Molecular weight: 326.8 g/mol

Ref: 3D-IGA98500